References
- DoteKSatoHTateishiHUchidaTIshiharaM1991Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 casesJ Cardiol21203141841907
- DrimalJZurova-NedelcevovaJKnezlVSotnikovaRNavarovaJ2006Cardiovascular toxicity of the first line cancer chemotherapeutic agents: doxorubicin, cyclophosphamide, streptozocin and bevacizumabNeuro Endocrinol Lett27Suppl 2176917159809
- Genentech, Inc2008Bevacizumab Prescribing Information [online] Accessed 23 May 2008. URL: http://www.gene.com/gene/products/information/pdf/avastin-prescribing.pdf
- HurstRAskewJReussC2006Transient midventricular ballooning syndromeJ Am Coll Cardiol485798316875987
- HurwitzHFehrenbacherLNovotnyW2004Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal CancerN Engl J Med35023354215175435
- IzumiyaYShiojimaISatoKSawyerDColussiWWalshK2006Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overloadHypertension478879316567591
- SandlerAGrayRPerryMC2006Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancerN Engl J Med35525425017167137
- ScappaticciFSkillingsJHoldenS2007Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumabJ Nat Cancer Inst991232917686822
- TrainaTRugoHDicklerM2007Bevacizumab for Advanced Breast CancerHematol Oncol Clin N Am2130319
- Van De WalleSGevaertSGheerhaertP2006Transient stress-induced cardiomyopathy with an “inverted takotsubo” contractile patternMayo Clin Proc81149950217120407
- ZacharyIMartinJ2006Viewpoint: an explanation for the cardiovascular effects of bevacizumab and rofecoxib?Circulation: European Perspectives7f173f5